Product
ECC5004
3 clinical trials
1 indication
Indication
Type 2 Diabetes MellitusClinical trial
A Phase 1, Open Label, Fixed Sequence Study to Evaluate the Effect of ECC5004 on the Single Dose Pharmacokinetics of Atorvastatin, Rosuvastatin, Digoxin and Midazolam in Healthy ParticipantsStatus: Recruiting, Estimated PCD: 2024-04-19
Clinical trial
An Open-Label, Randomized, Single Dose, Crossover Clinical Study to Assess the Relative Bioavailability of Current Tablet Formulation (F1) Compared to New Tablet Formulation (F2) of ECC5004 and Food Effects on F1 and F2 of ECC5004 in Healthy ParticipantsStatus: Recruiting, Estimated PCD: 2024-03-30
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Single and Repeated Dose Escalation, First-Time-In-Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ECC5004 in Healthy Participants and in Patients With Type 2 Diabetes MellitusStatus: Recruiting, Estimated PCD: 2023-10-06